Trial Profile
An open-label, single-arm, prospective study to evaluate the lipid-lowering efficacy and safety of simvastatin 40 mg tablet in patients with hypercholesterolemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 01 Feb 2007 Status changed from recruiting.
- 13 Dec 2006 New trial record.